Hone Bio
PrivateLast Round
Series A
Mar 16, 2021
Total Funding Raised
$6.5M
Company Overview
Hone Bio operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Series A round in March 2021.
Hone Bio is a biotechnology company developing a lipid nanoparticle (LNP) targeting technology for enhanced drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hone Bio Comparables
Compare Hone Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoVation Therapeutics | 85% | |
| Ligandal, Inc. | 84% | |
| Kamal Therapeutics, Inc. | 80% |
For institutional investors. Book with your work email.
Hone Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 16, 2021 | ||||
| Seed | Nov 25, 2019 |
For institutional investors. Book with your work email.
Hone Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Series A, Seed |
| Bristol Private Equity Club | Series A, Seed |
| Spin Up Science | Series A |
| Meltwind Advisory | Series A |
| University of Bristol Enterprise Fund | Series A, Seed |
| Science Creates Ventures | Series A |
| Luminous Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 212% MoM, from 485 to 1.5K.
- Mar 16, 2021
$5M round led by Science Creates Ventures.
For institutional investors. Book with your work email.
Hone Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hone Bio's valuation, stock price, and market status.
Is Hone Bio a public or private company?
Hone Bio is a private company.
What is the current stock price of Hone Bio?
Hone Bio is a private company, so its shares have no public market price. Caplight tracks Hone Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hone Bio worth (valuation)?
Valuation information for Hone Bio is not publicly available.
Can I buy Hone Bio stock?
Hone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hone Bio's last funding round?
Hone Bio's most recent funding round was Series A on March 16, 2021.
Who are the main investors in Hone Bio?
Key investors in Hone Bio include Spin Up Science, Science Creates Ventures.
Will Hone Bio IPO soon?
No public IPO plans have been announced for Hone Bio.
How can I track Hone Bio secondary market activity?
Caplight tracks bids, offers, and trades in Hone Bio's shares on secondary markets.